Morgan Stanley downgraded Inspire Medical (INSP) to Equal Weight from Overweight with a $130 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- Truist upgrades Inspire Medical to Buy after positive reimbursement ‘surprise’
- Inspire Medical upgraded to Buy from Hold at Truist
- Brinker upgraded, Coinbase downgraded: Wall Street’s top analyst calls
- Wolfe upgrades Inspire on ‘surprise’ Medicare reimbursement raise
- Inspire Medical upgraded to Outperform from Peer Perform at Wolfe Research